On this page
Stephen J Gold
Insider
First SEC filing: April 3, 2014 · Latest: April 3, 2014
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 24, 2019 | WKC | A | 5,321 | · | · | 15,487 Direct | +52.34% | Acquired | (price as of 2026-10-05) |
| May 24, 2018 | WKC | A | 7,434 | · | · | 10,166 Direct | +272.11% | Acquired | (price as of 2026-10-05) |
| Oct. 4, 2017 | WKC | A | 2,732 | · | · | 2,732 Direct | · | Acquired | (price as of 2026-10-05) |
| April 3, 2017 | CVS | A | 67,621 | $78.05 | $5,277,819 | 67,621 Direct | · | Acquired | 11.5% (price as of 2026-10-05) |
| April 3, 2017 | CVS | A | 8,648 | $78.05 | $674,976 | 46,818 Direct | +22.66% | Acquired | 11.5% (price as of 2026-10-05) |
| April 1, 2017 | CVS | F | 1,396 | $78.50 | $109,586 | 29,188 Direct | -4.56% | Disposed | 10.8% (price as of 2026-10-05) |
| Feb. 28, 2017 | CVS | F | 3,462 | $80.58 | $278,968 | 27,892 Direct | -11.04% | Disposed | 8.0% (price as of 2026-10-05) |
| Feb. 28, 2017 | CVS | A | 9,307 | $80.58 | $749,958 | 31,354 Direct | +42.21% | Acquired | 8.0% (price as of 2026-10-05) |
| May 5, 2016 | CVS | M | 9,798 | · | · | 63,440 Direct | -13.38% | Disposed | (price as of 2026-10-05) |
| May 5, 2016 | CVS | S 10b5-1 | 9,798 | $105.00 | $1,028,790 | 21,560 Direct | -31.25% | Disposed | -17.1% (price as of 2026-10-05) |
| May 5, 2016 | CVS | M | 9,798 | $47.29 | $463,347 | 31,358 Direct | +45.45% | Acquired | 84.0% (price as of 2026-10-05) |
| April 1, 2016 | CVS | A | 48,395 | $104.82 | $5,072,764 | 48,395 Direct | · | Acquired | -17.0% (price as of 2026-10-05) |
| April 1, 2016 | CVS | M | 21,922 | · | · | 73,238 Direct | -23.04% | Disposed | (price as of 2026-10-05) |
| April 1, 2016 | CVS | A | 6,439 | $104.82 | $674,936 | 40,862 Direct | +18.71% | Acquired | -17.0% (price as of 2026-10-05) |
| April 1, 2016 | CVS | F | 1,546 | $104.82 | $162,052 | 21,560 Direct | -6.69% | Disposed | -17.0% (price as of 2026-10-05) |
| April 1, 2016 | CVS | S 10b5-1 | 21,922 | $105.00 | $2,301,810 | 20,126 Direct | -52.14% | Disposed | -17.1% (price as of 2026-10-05) |
| April 1, 2016 | CVS | M | 21,922 | $47.29 | $1,036,691 | 42,048 Direct | +108.92% | Acquired | 84.0% (price as of 2026-10-05) |
| Feb. 29, 2016 | CVS | A | 7,816 | $97.17 | $759,481 | 20,126 Direct | +63.49% | Acquired | -10.5% (price as of 2026-10-05) |
| April 1, 2015 | CVS | A | 41,089 | $102.26 | $4,201,761 | 41,089 Direct | · | Acquired | -14.9% (price as of 2026-10-05) |
| April 1, 2015 | CVS | A | 5,867 | $102.26 | $599,959 | 37,403 Direct | +18.60% | Acquired | -14.9% (price as of 2026-10-05) |
| Feb. 27, 2015 | CVS | A | 6,991 | $103.87 | $726,155 | 6,991 Direct | · | Acquired | -16.2% (price as of 2026-10-05) |
| Feb. 27, 2015 | CVS | A | 1,432 | $103.87 | $148,742 | 11,905 Direct | +13.67% | Acquired | -16.2% (price as of 2026-10-05) |
| April 1, 2014 | CVS | A | 33,569 | $74.29 | $2,493,841 | 33,569 Direct | · | Acquired | 17.1% (price as of 2026-10-05) |
| April 1, 2014 | CVS | A | 20,191 | $74.29 | $1,499,989 | 31,536 Direct | +177.97% | Acquired | 17.1% (price as of 2026-10-05) |
| April 1, 2014 | CVS | A | 5,384 | $74.29 | $399,977 | 11,345 Direct | +90.32% | Acquired | 17.1% (price as of 2026-10-05) |
| April 1, 2013 | CVS | A | 25,571 | $54.53 | $1,394,387 | 25,571 Direct | · | Acquired | 59.6% (price as of 2026-10-05) |
| April 1, 2013 | CVS | A | 5,961 | $54.53 | $325,053 | 5,961 Direct | · | Acquired | 59.6% (price as of 2026-10-05) |
| July 9, 2012 | CVS | A | 95,160 | $47.29 | $4,500,116 | 95,160 Direct | · | Acquired | 84.0% (price as of 2026-10-05) |
| July 9, 2012 | CVS | A | 9,516 | $47.29 | $450,012 | 9,516 Direct | · | Acquired | 84.0% (price as of 2026-10-05) |
| July 9, 2012 | CVS | P | 9,516 | $47.29 | $450,012 | 9,516 Direct | · | Acquired | 84.0% (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 3, 2017 | CVS | Stock Option | Common Stock | $78.05 | April 3, 2024 | 67,621 | Acquired |
| May 5, 2016 | CVS | Stock Option | Common Stock | $47.29 | July 9, 2022 | 9,798 | Disposed |
| April 1, 2016 | CVS | Stock Option | Common Stock | $104.82 | April 1, 2023 | 48,395 | Acquired |
| April 1, 2016 | CVS | Stock Option | Common Stock | $47.29 | July 9, 2022 | 21,922 | Disposed |
| April 1, 2015 | CVS | Stock Option | Common Stock | $102.26 | April 1, 2022 | 41,089 | Acquired |
| April 1, 2014 | CVS | Stock Option | Common Stock | $74.29 | April 1, 2021 | 33,569 | Acquired |
| April 1, 2013 | CVS | Stock Option | Common Stock | $54.53 | April 1, 2020 | 25,571 | Acquired |
| July 9, 2012 | CVS | Stock Option | Common Stock | $47.29 | July 9, 2022 | 95,160 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).